The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from knowing whether medications made overseas are tainted by manufacturing failures.
Gizmodo
The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from knowing whether medications made overseas are tainted by manufacturing failures.